No. Uterus transplants are not a current option for male bodies, and no clinical program has reported one.
That’s the straight answer. A uterus transplant is a rare, complex procedure built for patients with absolute uterine-factor infertility, which means they cannot carry a pregnancy because the uterus is absent or does not work. Right now, the surgery has been used in women, not in male bodies.
That gap is not about one missing step. It comes down to a stack of hurdles: pelvic anatomy, blood vessel setup, hormone control, embryo transfer planning, placenta growth, delivery planning, and the added strain of anti-rejection drugs. Put all that together, and the idea stays in the research and ethics space rather than real-world clinical care.
So if you landed here looking for a clean, honest answer, here it is: medicine is not there yet, and it is not offered as a present-day treatment.
Can A Man Have A Uterus Transplant? Current Medical Reality
The present medical reality is simple. No hospital program has reported a uterus transplant into a man, and no birth has come from one. Published clinical work has centered on women with absolute uterine-factor infertility. In that group, uterus transplant has moved from a bold idea to a small but real clinical practice, with live births reported after successful grafts.
A 2024 JAMA report on uterus transplant in women with absolute uterine-factor infertility described a 20-patient series in the United States. Fourteen had a working graft, and all 14 later had at least one live birth. That shows the procedure can work in the patient group it was built for. It also shows the price: graft failure, infection, rejection episodes, donor risk, and pregnancy complications were all part of the picture.
That matters because even in the group most suited to the operation, this is still one of the toughest surgeries in reproductive medicine. It is not a plug-and-play transplant. It is temporary, tightly timed, and wrapped around IVF, anti-rejection medication, close monitoring, cesarean delivery, and later removal of the transplanted uterus.
Why The Answer Is No Right Now
The short version is that a uterus does not work on its own. It needs the right space, blood flow, hormonal setting, cervical access, and a safe way to carry and deliver a fetus. In a male body, each of those pieces raises hard medical questions.
Pelvic Anatomy Is A Major Barrier
The female pelvis is shaped for the organs and ligament attachments involved in pregnancy. Surgeons also need suitable vessels for transplant hookup and stable placement of the uterus in the pelvis. Male pelvic anatomy is different in shape, depth, and available soft-tissue layout. That makes graft placement and long-term stability harder from the start.
Pregnancy Needs More Than A Working Uterus
A successful graft is only the opening chapter. The lining of the uterus has to respond in a controlled way, embryos have to be created and transferred, the placenta has to implant and grow, and the pregnancy has to be carried under close watch. In male bodies, there is no natural cervix-vagina setup for the standard route used in current uterus-transplant care, and there is no established clinical path for each later stage.
Anti-Rejection Drugs Raise The Stakes
Any transplant brings rejection risk, infection risk, and drug side effects. Uterus transplant adds another layer because the goal is not just organ survival. The goal is a pregnancy, then delivery, then removal of the graft. So the patient takes on major surgery and immunosuppression for a temporary organ. Even in current female recipients, that risk load is not small.
Delivery Would Still Need Surgical Planning
Uterus-transplant births are delivered by cesarean section. In a male body, there is no standard obstetric route, no routine surgical playbook, and no live clinical track record to lean on. That leaves teams with too many unknowns to offer the procedure as care.
What Uterus Transplant Looks Like Today
One reason this topic gets muddled is that many people hear “transplant” and think of a single operation. Uterus transplant is not that. It is a sequence of linked steps, each with its own risk.
- Embryos are usually created with IVF before transplant.
- A uterus is recovered from a living or deceased donor.
- The recipient has transplant surgery and starts anti-rejection medication.
- The graft is monitored for blood flow, infection, and rejection.
- Embryo transfer happens only after the graft is stable.
- Pregnancy is monitored as high risk.
- Delivery is by cesarean section.
- The transplanted uterus is later removed so long-term immunosuppression can stop.
The UK program page from Womb Transplant UK lays out the current model in plain terms: the program is for women with absolute uterine infertility, with strict age rules, embryo requirements, transplant surgery, and anti-rejection follow-up. That is a good snapshot of how narrow and controlled the field still is.
| Stage | What Happens | Why It Matters For This Question |
|---|---|---|
| Patient selection | Programs screen for uterine-factor infertility, general health, and IVF readiness. | Current programs are built around female recipients. |
| Embryo creation | Embryos are made and frozen before transplant. | Pregnancy after transplant depends on IVF from the start. |
| Donor surgery | The uterus is recovered with long, usable blood vessels. | Vessel length and anatomy shape whether transplant is even possible. |
| Recipient surgery | The uterus is placed in the pelvis and attached to vessels. | Male pelvic anatomy creates added surgical hurdles. |
| Immunosuppression | Anti-rejection drugs start right after surgery. | Drug burden is one of the biggest trade-offs. |
| Graft monitoring | Teams watch for rejection, infection, and poor blood flow. | Even standard recipients need tight follow-up. |
| Embryo transfer | Transfer happens only after the graft is stable. | No male-body clinical route has been established. |
| Pregnancy care | Pregnancy is handled as high risk. | The placenta, hormones, and fetal growth all need a proven care path. |
| Delivery and graft removal | Birth is by cesarean section, then the graft is later removed. | There is no routine obstetric plan for male recipients. |
Where Research Stands On Male Or Transgender Recipients
This is where a lot of headlines get ahead of the science. Papers have asked whether uterus transplant could one day be attempted in transgender women or other recipients with male anatomy. Those papers are not announcing a ready treatment. They are asking whether the idea is biologically and ethically testable.
A JAMA Network Open survey on uterus transplant in transgender women found strong interest among respondents and called for animal and cadaveric research to test feasibility. That wording matters. It places the topic at an early research stage, not at the level of a clinical service a patient can book.
So the honest reading is this: there is interest, there is debate, and there are papers laying out what would need to be solved. But there is no established treatment, no routine surgical method, no live human clinical series, and no birth data in male recipients.
Questions Research Would Need To Answer
Before any team could even think about a clinical trial, several problems would need answers that are clear, repeatable, and safe enough for ethics boards and transplant centers.
- Which vessels would offer reliable inflow and outflow for the graft?
- How would the uterus be anchored in the pelvis over time?
- What route would be used for embryo transfer and later monitoring?
- How would hormonal preparation be standardized?
- How would placenta growth and fetal development be tracked?
- What surgical plan would be used for delivery?
- How would teams weigh transplant risk against the non-life-saving nature of the procedure?
None of those are side notes. They sit in the center of the issue.
| Question | Current Answer | Plain-English Meaning |
|---|---|---|
| Has a man received a uterus transplant in clinical care? | No reported clinical case. | This is not a present-day treatment option. |
| Has pregnancy after male-recipient uterus transplant been reported? | No. | There is no human birth data to point to. |
| Is uterus transplant done in medicine today? | Yes, in selected women with uterine-factor infertility. | The procedure exists, but in a narrow patient group. |
| Is the surgery low risk? | No. | It involves major operations, anti-rejection drugs, and high-risk pregnancy care. |
| Are male-body recipients being offered this now? | No. | The science has not reached clinical use. |
What This Means Right Now
If you are asking the question in a practical sense, the answer stays no. A man cannot get a uterus transplant as a current medical service. The field is still narrow even for the patients already included, and it has not crossed into male-recipient clinical care.
If you are asking whether medicine may test it later, the answer shifts a bit. There are published arguments that the idea deserves research. Still, “deserves research” is a long way from “works in patients.” Medicine often spends years between those two points, and some ideas never make the jump.
That is why the cleanest answer is also the most useful one: uterus transplant is real, but only in a tightly defined clinical setting, and not for men at this time.
References & Sources
- JAMA.“Uterus Transplant in Women With Absolute Uterine-Factor Infertility.”Provides current clinical data on recipient outcomes, live births, graft success, and complications in women who received uterus transplants.
- Womb Transplant UK.“The UK Womb Transplant Programmes and Procedure.”Spells out who current womb-transplant programs are for and outlines the present treatment pathway, donor routes, and monitoring steps.
- JAMA Network Open.“Perceptions and Motivations for Uterus Transplant in Transgender Women.”Shows that interest exists while also stating that animal and cadaveric research is still needed to test feasibility in transgender women.
